Mostrar el registro sencillo del ítem

dc.contributorUniversitat Ramon Llull. Facultat de Ciències de la Salut Blanquerna
dc.contributor.authorRuiz-Ramos, Jesús
dc.contributor.authorHernández Hernández, Marta
dc.contributor.authorJuanes Borrego, Ana
dc.contributor.authorMilà, Raimon
dc.contributor.authorMangues-Bafalluy, Maria A.
dc.contributor.authorMestres Miralles, Concepción
dc.date.accessioned2024-01-04T08:14:56Z
dc.date.available2024-01-04T08:14:56Z
dc.date.created2021-11
dc.date.issued2021-07
dc.identifier.urihttp://hdl.handle.net/20.500.14342/3703
dc.description.abstractObjectives Pharmacists’ care has an essential role in multidisciplinary teams in charge of chronic patients. However, data available on the clinical outcomes of these activities appear inconclusive. This study aimed to systematically investigate the effect of multidisciplinary teams that include coordinated pharmaceutical care on clinical outcomes. Design Systematic review and meta-analysis. Relevant studies identified from MEDLINE, Cochrane, Web of Science, Scopus and CINAHL databases were analyzed. The search included randomized clinical trials published in 2000-2018. Included studies were all published studies in English that compared the effectiveness of multidisciplinary teams including pharmacist care to usual care. Meta-analysis was carried out using a random effects model, and subgroup analysis was conducted to determine the sources of heterogeneity. Setting and Participants 29 studies involving 4186 adult patients were included. Measures Follow-up time varied from 30 to 180 days. The most common primary endpoint was the frequency of hospitalizations or readmissions, followed by variation in clinical parameter variables related to quality of prescription, treatment adherence and costs. Results Twelve (41.3%) of the included studies scored low risk of bias according to the AMSTAR-2 scale, the remaining 17 (58.7%) being classified as intermediate risk. The intervention of a multidisciplinary team reduced the probability of readmission by 32% [odds ratio (OR) 0.74, 95% confidence interval (CI) 0.62-0.89]. Six of the 29 (20.7%) studies included met the inclusion criteria of the meta-analysis on quality-of-life outcomes. The intervention of the multidisciplinary team represented a significant increase in patients’ quality of life (OR 0.58, 95% CI 0.47-0.69). Analysis of heterogeneity showed a significant difference between the studies. No evidence of publication bias was identified. Conclusions and Implications Multidisciplinary programs that include pharmaceutical care reduce the risk of visiting hospitals and improve patients’ quality of life. This review supports the importance of the pharmacists as part of multidisciplinary teams.ca
dc.format.extent9 p.ca
dc.language.isoengca
dc.publisherElsevierca
dc.relation.ispartofJournal of the American Medical Directors Association (JAMDA), 2021, vol. 22, núm. 12, p. 2518-2526ca
dc.rights© AMDA - The Society for Post-Acute and Long-Term Care Medicineca
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subject.otherFarmàciaca
dc.subject.otherAssistència sanitàriaca
dc.subject.otherServeis farmacèuticsca
dc.titleThe Impact of pharmaceutical care in multidisciplinary teams on health outcomes: systematic review and meta-analysisca
dc.typeinfo:eu-repo/semantics/articleca
dc.rights.accessLevelinfo:eu-repo/semantics/openAccess
dc.embargo.terms12 mesosca
dc.subject.udc615ca
dc.identifier.doihttps://doi.org/10.1016/j.jamda.2021.05.038ca
dc.description.versioninfo:eu-repo/semantics/acceptedVersionca


Ficheros en el ítem

 

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

© AMDA - The Society for Post-Acute and Long-Term Care Medicine
Excepto si se señala otra cosa, la licencia del ítem se describe como http://creativecommons.org/licenses/by-nc-nd/4.0/
Compartir en TwitterCompartir en LinkedinCompartir en FacebookCompartir en TelegramCompartir en WhatsappImprimir